8-KOther Events

WELLTOWER INC. 8-K Report, Corporate Update (Nov 23, 2004)

Filed November 23, 2004For Securities:WELL

Summary

This 8-K filing from Health Care REIT, Inc. (now Welltower Inc.) on November 23, 2004, primarily concerns updates to the company's insider trading policy and specific trading plans adopted by its executives. The company had previously modified its insider trading policy to permit executives to sell company securities through pre-arranged trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934. This filing specifically details a new Rule 10b5-1 trading plan entered into by Erin C. Ibele, Vice President and Corporate Secretary. This plan authorizes the exercise of stock options and the sale of up to 23,297 shares of common stock between December 20, 2004, and June 30, 2005. The monthly sales range from 3,200 to 4,097 shares, providing a structured approach to insider stock sales.

Key Highlights

  • 1Health Care REIT, Inc. (now Welltower Inc.) is providing an update on its insider trading policy.
  • 2The company previously allowed executives to sell securities via Rule 10b5-1 trading plans.
  • 3Erin C. Ibele, VP and Corporate Secretary, entered into a new Rule 10b5-1 trading plan.
  • 4Ms. Ibele's plan allows for the exercise of stock options and sale of up to 23,297 shares.
  • 5The trading plan is effective from December 20, 2004, to June 30, 2005.
  • 6Monthly sales under the plan are structured, ranging from 3,200 to 4,097 shares.
  • 7Actual sales details will be reported on Form 4 filings.

Frequently Asked Questions

The main purpose of this 8-K filing is to report an update to Health Care REIT, Inc.'s (now Welltower Inc.) insider trading policy, specifically detailing a new Rule 10b5-1 trading plan established by an executive, Erin C. Ibele.

Rule 10b5-1 provides an affirmative defense to insider trading allegations. It allows company insiders to set up pre-arranged trading plans for buying or selling company stock at times when they do not possess material non-public information. This filing indicates that the company's executives, including Ms. Ibele, are utilizing these plans.

Under the new Rule 10b5-1 plan, Erin C. Ibele is authorized to exercise options and sell up to a total of 23,297 shares of the company's common stock.

The trading plan for Ms. Ibele is scheduled to take place between December 20, 2004, and June 30, 2005. The sales are structured to occur in monthly tranches, ranging from 3,200 to 4,097 shares per month.